{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:20:45Z","timestamp":1791022845919,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T00:00:00Z","timestamp":1369785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s11886-013-0374-2","type":"journal-article","created":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T06:33:45Z","timestamp":1369722825000},"source":"Crossref","is-referenced-by-count":17,"title":["Risk of Cardiovascular Events with Hormonal Contraception: Insights from the Danish Cohort Study"],"prefix":"10.1007","volume":"15","author":[{"given":"Omosalewa O.","family":"Lalude","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,29]]},"reference":[{"issue":"29","key":"374_CR1","first-page":"1","volume":"23","author":"WD Mosher","year":"2010","unstructured":"Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat. 2010;23(29):1\u201344.","journal-title":"Vital Health Stat"},{"key":"374_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacc.2008.09.042","volume":"53","author":"CL Shufelt","year":"2009","unstructured":"Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol. 2009;53:221\u201331.","journal-title":"J Am Coll Cardiol"},{"key":"374_CR3","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","volume":"ii","author":"W Jordan","year":"1961","unstructured":"Jordan W. Pulmonary embolism. Lancet. 1961;ii:1146\u20137.","journal-title":"Lancet"},{"key":"374_CR4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/bmj.2.5313.1191-a","volume":"ii","author":"I Lorentz","year":"1962","unstructured":"Lorentz I. Parietal lesions and Enavid. BMJ. 1962;ii:1191.","journal-title":"BMJ"},{"key":"374_CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(63)91117-6","volume":"1","author":"J Boyce","year":"1963","unstructured":"Boyce J, Fawcett JW, Noall EW. Coronary thrombosis and Conovid. Lancet. 1963;1:111.","journal-title":"Lancet"},{"key":"374_CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","volume":"312","author":"WO Spitzer","year":"1996","unstructured":"Spitzer WO, Lewis MA, Heinemann LA, et al. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Results from the Transnational research group on oral contraceptives and the health of young women. BMJ. 1996;312:83\u20138.","journal-title":"BMJ"},{"key":"374_CR7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","volume":"346","author":"H Jick","year":"1995","unstructured":"Jick H, Jick SS, Gurewich V, et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995;346:1589\u201393.","journal-title":"Lancet"},{"key":"374_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0010-7824(01)00306-7","volume":"65","author":"O Lidegaard","year":"2002","unstructured":"Lidegaard O, Kreiner S. Contraceptives and cerebral thrombosis: a five-year national case-control study. Contraception. 2002;65:197\u2013205.","journal-title":"Contraception"},{"key":"374_CR9","doi-asserted-by":"crossref","unstructured":"Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study. WHO collaborative study of cardiovascular disease and steroid hormone contraception. Lancet 1997;349:1202-9.","DOI":"10.1016\/S0140-6736(97)02358-1"},{"key":"374_CR10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","volume":"345","author":"BC Tanis","year":"2001","unstructured":"Tanis BC, Van den Bosch MA, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med. 2001;345:1787\u201393.","journal-title":"N Engl J Med"},{"key":"374_CR11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archinte.161.8.1065","volume":"161","author":"L Rosenberg","year":"2001","unstructured":"Rosenberg L, Palmer JR, Rao RS, Shapiro S. Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med. 2001;161:1065\u201370.","journal-title":"Arch Intern Med"},{"key":"374_CR12","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.318.7198.1579","volume":"318","author":"N Dunn","year":"1999","unstructured":"Dunn N, Thorogood M, Faragher B, et al. Oral contraceptives and myocardial infarction: results of the MICA case-control study. BMJ. 1999;318:1579\u201383.","journal-title":"BMJ"},{"key":"374_CR13","doi-asserted-by":"crossref","unstructured":"\u2022 van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009;339:b2921. doi: 10.1136\/bmj.b2921 . This contains recent data on the increased risk of VT with 3rd and 4th generation OCs.","DOI":"10.1136\/bmj.b2921"},{"key":"374_CR14","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","volume":"340","author":"L Parkin","year":"2011","unstructured":"\u2022 Parkin L, Sharples K, Hernandez RK, Jick SS. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK general practice research database. BMJ. 2011;340:d2139. doi: 10.1136\/bmj.d2139 . This contains recent data on the increased risk of VT with 4th generation OCs.","journal-title":"BMJ"},{"key":"374_CR15","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","volume":"340","author":"SS Jick","year":"2011","unstructured":"\u2022 Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: Case-control study using United States claims data. BMJ. 2011;340:d2151. doi: 10.1136\/bmj.d2151 . This contains recent data on the increased risk of VT with 4th generation OCs.","journal-title":"BMJ"},{"key":"374_CR16","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"O Lidegaard","year":"2011","unstructured":"\u2022 Lidegaard O, Nielsen LH, Skovlund CW, et al. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ. 2011;343:d6423. doi: 10.1136\/bmj.d6423 . This contains recent data on the increased risk of VT with 3rd and 4th generation OCs.","journal-title":"BMJ"},{"key":"374_CR17","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","volume":"344","author":"O Lidegaard","year":"2012","unstructured":"\u2022 Lidegaard O, Nielsen LH, Skovlund CW, et al. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, denmark 2001-10. BMJ. 2012;344:e2990. doi: 10.1136\/bmj.e2990 . This contains recent data on the risk of VT with transdermal patches and vaginal rings.","journal-title":"BMJ"},{"key":"374_CR18","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.STR.0000015345.61324.3F","volume":"33","author":"JM Kemmeren","year":"2002","unstructured":"Kemmeren JM, Tanis BC, van den Bosch MA, et al. Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke. 2002;33:1202\u20138.","journal-title":"Stroke"},{"key":"374_CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","volume":"75","author":"JC Dinger","year":"2007","unstructured":"\u2022 Dinger JC, Heinemann LA, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the european active surveillance study on oral contraceptives based on 142,475 women-years of observation. Contraception. 2007;75:344\u201354. This the a recent cohort study that examines the risk of AT with oral contraceptive use.","journal-title":"Contraception"},{"key":"374_CR20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.fertnstert.2006.11.206","volume":"88","author":"KL Margolis","year":"2007","unstructured":"Margolis KL, Adami HO, Luo J, et al. A prospective study of oral contraceptive use and risk of myocardial infarction among swedish women. Fertil Steril. 2007;88:310\u20136.","journal-title":"Fertil Steril"},{"key":"374_CR21","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","volume":"366","author":"O Lidegaard","year":"2012","unstructured":"\u2022\u2022 Lidegaard O, Lokkegaard E, Jensen A, et al. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366:2257\u201366. This the largest recent cohort study that examines the risk of MI and stroke with oral contraceptive use.","journal-title":"N Engl J Med"},{"key":"374_CR22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","volume":"87","author":"S Sidney","year":"2013","unstructured":"\u2022 Sidney S, Cheetham TC, Connell FA, et al. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception. 2013;87:93\u2013100. This the most recent cohort study that examines the risk of AT with oral contraceptive use.","journal-title":"Contraception"},{"key":"374_CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0010-7824(95)00138-7","volume":"52","author":"O Lidegaard","year":"1995","unstructured":"Lidegaard O. Decline in cerebral thromboembolism among young women after introduction of low-dose oral contraceptives: an incidence study for the period 1980-1993. Contraception. 1995;52:85\u201392.","journal-title":"Contraception"},{"key":"374_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(99)01013-2","volume":"354","author":"NR Poulter","year":"1999","unstructured":"Poulter NR, Chang CL, Farley TM, et al. Effect on stroke of different progestagens in low oestrogen dose oral contraceptives. WHO collaborative study of cardiovascular disease and steroid hormone contraception. Lancet. 1999;354:301\u20132.","journal-title":"Lancet"},{"key":"374_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(97)00204-7","volume":"57","author":"LA Heinemann","year":"1998","unstructured":"Heinemann LA, Lewis MA, Spitzer WO, et al. Thromboembolic stroke in young women. A European case-control study on oral contraceptives. The Transnational research group on oral contraceptives and the health of young women. Contraception. 1998;57:29\u201337.","journal-title":"Contraception"},{"key":"374_CR26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0010-7824(98)00032-8","volume":"57","author":"O Lidegaard","year":"1998","unstructured":"Lidegaard O, Kreiner S. Cerebral thrombosis and oral contraceptives. A case-control study. Contraception. 1998;57:303\u201314.","journal-title":"Contraception"},{"key":"374_CR27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.298.6667.165","volume":"298","author":"P Croft","year":"1989","unstructured":"Croft P, Hannaford P. Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners\u2019 oral contraception study. BMJ. 1989;298:165\u20139.","journal-title":"BMJ"},{"key":"374_CR28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM198811173192004","volume":"319","author":"MJ Stampfer","year":"1988","unstructured":"Stampfer MJ, Willett WC, Colditz GA, et al. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med. 1988;319:1313\u20137.","journal-title":"N Engl J Med"},{"key":"374_CR29","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1471-0528.1998.tb10235.x","volume":"105","author":"J Mant","year":"1998","unstructured":"Mant J, Painter R, Vessey M. Risk of myocardial infarction, angina and stroke in users of oral contraceptives: an updated analysis of a cohort study. Br J Obstet Gynaecol. 1998;105:890\u20136.","journal-title":"Br J Obstet Gynaecol"},{"key":"374_CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.0954-6820.1982.tb03186.x","volume":"212","author":"JT Salonen","year":"1982","unstructured":"Salonen JT. Oral contraceptives, smoking and risk of myocardial infarction in young women. A longitudinal population study in eastern Finland. Acta Med Scand. 1982;212:141\u20134.","journal-title":"Acta Med Scand"},{"key":"374_CR31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(97)00118-2","volume":"56","author":"MA Lewis","year":"1997","unstructured":"Lewis MA, Heinemann LA, Spitzer WO, et al. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational study on oral contraceptives and the health of young women. Contraception. 1997;56:129\u201340.","journal-title":"Contraception"},{"key":"374_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0010-7824(01)00172-X","volume":"63","author":"NR Dunn","year":"2001","unstructured":"Dunn NR, Arscott A, Thorogood M. The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study. Contraception. 2001;63:65\u20139.","journal-title":"Contraception"},{"key":"374_CR33","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMe1204769","volume":"366","author":"DB Petitti","year":"2012","unstructured":"\u2022 Petitti DB. Hormonal contraceptives and arterial thrombosis\u2013not risk-free but safe enough. N Engl J Med. 2012;366:2316\u20138. This the editorial on the recent Danish Cohort study that examines the risk of MI and stroke with oral contraceptive use.","journal-title":"N Engl J Med"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-013-0374-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-013-0374-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-013-0374-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:23Z","timestamp":1559433383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-013-0374-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,29]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1007\/s11886-013-0374-2","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,29]]},"article-number":"374"}}